CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8300
-0.0100 (-1.19%)
Jun 2, 2025, 3:32 PM HKT
127.40%
Market Cap 8.07B
Revenue (ttm) 5.52B
Net Income (ttm) -126.55M
Shares Out 9.61B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,892,000
Average Volume 10,901,444
Open 0.8300
Previous Close 0.8400
Day's Range 0.8000 - 0.8300
52-Week Range 0.3200 - 1.1000
Beta 0.38
RSI 53.86
Earnings Date May 13, 2025

About HKG:0775

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines.... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 2,033
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0775
Full Company Profile

Financial Performance

Financial Statements

News

CK Life’s new CEO counts on Big Pharma experience to boost new drug success, earnings

Lance Yuen spent two decades at Bristol-Myers Squibb and Bayer in the region before becoming the CEO at CK Life Sciences last month.

8 months ago - South China Morning Post